HEADER HYDROLASE 17-SEP-04 1W8B TITLE FACTOR7 - 413 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: BLOOD COAGULATION FACTOR VIIA; COMPND 3 CHAIN: H; COMPND 4 FRAGMENT: FACTOR VII HEAVY CHAIN, RESIDUES 213-466; COMPND 5 SYNONYM: SERUM PROTHROMBIN CONVERSION ACCELERATOR, SPCA, COMPND 6 PROCONVERTIN, EPTACOG ALFA, NOVOSEVEN; COMPND 7 EC: 3.4.21.21; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: BLOOD COAGULATION FACTOR VIIA; COMPND 11 CHAIN: L; COMPND 12 FRAGMENT: FACTOR VII LIGHT CHAIN, RESIDUES 148-204; COMPND 13 SYNONYM: SERUM PROTHROMBIN CONVERSION ACCELERATOR, SPCA, COMPND 14 PROCONVERTIN, EPTACOG ALFA, NOVOSEVEN; COMPND 15 EC: 3.4.21.21; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SERINE PROTEASE, COAGULATION, ENZYME COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.ACKERMANN,L.ALIG,D.W.BANNER,H.-J.BOEHM,K.GROEBKE-ZBINDEN,K.HILPERT, AUTHOR 2 T.LAVE,H.KUEHNE,U.OBST-SANDER,M.A.RIEDERER,M.STAHL,T.B.TSCHOPP, AUTHOR 3 L.WEBER,H.P.WESSEL REVDAT 4 06-NOV-24 1W8B 1 REMARK REVDAT 3 13-DEC-23 1W8B 1 LINK REVDAT 2 24-FEB-09 1W8B 1 VERSN REVDAT 1 25-OCT-05 1W8B 0 JRNL AUTH K.GROEBKE-ZBINDEN,U.OBST-SANDER,K.HILPERT,H.KUEHNE, JRNL AUTH 2 D.W.BANNER,H.-J.BOEHM,M.STAHL,J.ACKERMANN,L.ALIG,L.WEBER, JRNL AUTH 3 H.P.WESSEL,M.A.RIEDERER,T.B.TSCHOPP,T.LAVE JRNL TITL SELECTIVE AND ORALLY BIOAVAILABLE PHENYLGLYCINE TISSUE JRNL TITL 2 FACTOR/FACTOR VIIA INHIBITORS JRNL REF BIOORG.MED.CHEM.LETT. V. 15 5344 2005 JRNL REFN ISSN 0960-894X JRNL PMID 16213138 JRNL DOI 10.1016/J.BMCL.2005.04.079 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 72.36 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 75.8 REMARK 3 NUMBER OF REFLECTIONS : 7847 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 392 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.08 REMARK 3 REFLECTION IN BIN (WORKING SET) : 603 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2340 REMARK 3 BIN FREE R VALUE SET COUNT : 36 REMARK 3 BIN FREE R VALUE : 0.4000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2334 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 59 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.77000 REMARK 3 B22 (A**2) : 0.77000 REMARK 3 B33 (A**2) : -1.54000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.503 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.278 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 14.796 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.913 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.843 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2419 ; 0.007 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3297 ; 1.136 ; 1.971 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 299 ; 5.718 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 97 ;34.114 ;23.093 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 371 ;15.881 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;16.310 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 363 ; 0.078 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1844 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1111 ; 0.197 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1608 ; 0.305 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 127 ; 0.154 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 34 ; 0.167 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 5 ; 0.066 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1530 ; 0.394 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2412 ; 0.698 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1035 ; 0.698 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 885 ; 1.230 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. THIS ENZYME-INHIBITOR COMPLEX WAS RECENTLY REMARK 3 REDETERMINED AT HIGH RESOLUTION IN A DIFFERENT SPACE GROUP REMARK 3 (1W7X.PDB). THIS ORIGINAL STRUCTURE IS AT LOW RESOLUTION AND THE REMARK 3 DATA IS INCOMPLETE. NEVERTHELESS THE INHIBITOR BIND MODE IS WELL REMARK 3 DETERMINED. CURIOUSLY ONE INHIBITOR SUBSTITUENT IN THIS REMARK 3 STRUCTURE IS DISPLACED FROM ITS POSITION SEEN IN RELATED REMARK 3 STRUCTURES, AND RESIDUES FROM THE NEXT MOLECULE IN THE CRYSTAL REMARK 3 FILL THE BINDING POCKET. THE LOOP 140-150 IS NOT SEEN, AND REMARK 3 POSSIBLY SUFFERED PROTEOLYSIS. REMARK 4 REMARK 4 1W8B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-SEP-04. REMARK 100 THE DEPOSITION ID IS D_1290021082. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-APR-98 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM1A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.873 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23089 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.820 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 75.0 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : 0.16000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.82 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 62.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1W0Y REMARK 200 REMARK 200 REMARK: ONLY 27DEGREES OF DATA WERE COLLECTED, SO COMPLETENESS IS REMARK 200 VERY POOR. ALSO THERE WAS SEVERE ICING. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.88400 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 41.42300 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 41.42300 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 110.82600 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 41.42300 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 41.42300 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 36.94200 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 41.42300 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 41.42300 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 110.82600 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 41.42300 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 41.42300 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 36.94200 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 73.88400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN H 143 REMARK 465 LEU H 144 REMARK 465 LEU H 145 REMARK 465 ASP H 146 REMARK 465 ARG H 147 REMARK 465 GLY H 148 REMARK 465 ALA H 149 REMARK 465 ARG L 144 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS L 143 CA C O CB CG CD CE REMARK 470 LYS L 143 NZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS H 20 NZ REMARK 480 LYS H 60C CG CD CE NZ REMARK 480 ASN H 60D CB CG OD1 ND2 REMARK 480 GLN H 110 CD OE1 NE2 REMARK 480 GLN H 166 CG CD OE1 NE2 REMARK 480 LYS H 170D CD CE NZ REMARK 480 ASP H 170G CB CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LYS H 20 CE LYS H 20 NZ -0.454 REMARK 500 LYS H 60C CB LYS H 60C CG -0.373 REMARK 500 ASN H 60D CA ASN H 60D CB -0.230 REMARK 500 GLN H 110 CG GLN H 110 CD -0.366 REMARK 500 GLN H 166 CB GLN H 166 CG -0.211 REMARK 500 ASP H 170G CA ASP H 170G CB -0.221 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS H 20 CD - CE - NZ ANGL. DEV. = -14.5 DEGREES REMARK 500 GLN H 166 CA - CB - CG ANGL. DEV. = 16.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE H 60B 116.14 -16.38 REMARK 500 LYS H 60C -64.58 -103.54 REMARK 500 HIS H 71 -59.10 -133.14 REMARK 500 ALA H 152 94.95 175.80 REMARK 500 GLU H 178 3.43 -65.76 REMARK 500 SER H 195 128.53 -39.27 REMARK 500 SER H 214 -74.76 -107.12 REMARK 500 GLN L 100 -93.51 -114.64 REMARK 500 GLU L 142 -120.04 -148.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA H1258 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU H 70 OE1 REMARK 620 2 ASP H 72 O 85.9 REMARK 620 3 GLU H 75 O 160.9 78.8 REMARK 620 4 GLU H 80 OE2 99.7 170.5 97.0 REMARK 620 5 HOH H2013 O 90.4 87.9 77.8 99.6 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA H1258 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 413 H1259 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BF9 RELATED DB: PDB REMARK 900 N-TERMINAL EGF-LIKE DOMAIN FROM HUMAN FACTOR VII, NMR, 23 STRUCTURES REMARK 900 RELATED ID: 1CVW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVE SITE-INHIBITED HUMAN COAGULATION FACTOR REMARK 900 VIIA (DES-GLA) REMARK 900 RELATED ID: 1DAN RELATED DB: PDB REMARK 900 COMPLEX OF ACTIVE SITE INHIBITED HUMAN BLOOD COAGULATION FACTOR REMARK 900 VIIA WITH HUMAN RECOMBINANT SOLUBLE TISSUE FACTOR REMARK 900 RELATED ID: 1DVA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE PEPTIDE EXOSITE REMARK 900 INHIBITOR E-76 AND COAGULATION FACTOR VIIA REMARK 900 RELATED ID: 1F7E RELATED DB: PDB REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, REMARK 900 20 STRUCTURES REMARK 900 RELATED ID: 1F7M RELATED DB: PDB REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, REMARK 900 MINIMIZED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1FAK RELATED DB: PDB REMARK 900 HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA REMARK 900 INHIBITED WITH A BPTI-MUTANT REMARK 900 RELATED ID: 1FF7 RELATED DB: PDB REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII REMARK 900 (FUCOSYLATED AT SER-60), NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1FFM RELATED DB: PDB REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII REMARK 900 (FUCOSYLATED AT SER-60), NMR, MINIMIZED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1J9C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TISSUE FACTOR-FACTOR VIIA COMPLEX REMARK 900 RELATED ID: 1JBU RELATED DB: PDB REMARK 900 COAGULATION FACTOR VII ZYMOGEN (EGF2/PROTEASE) IN COMPLEX WITH REMARK 900 INHIBITORY EXOSITE PEPTIDE A -183 REMARK 900 RELATED ID: 1KLI RELATED DB: PDB REMARK 900 COFACTOR-AND SUBSTRATE-ASSISTED ACTIVATION OF FACTOR VIIA REMARK 900 RELATED ID: 1KLJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF UNINHIBITED FACTOR VIIA REMARK 900 RELATED ID: 1NL8 RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX REMARK 900 RELATED ID: 1QFK RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE REMARK 900 TRIGGERING OF BLOOD COAGULATION REMARK 900 RELATED ID: 1W0Y RELATED DB: PDB REMARK 900 TF7A_3771 COMPLEX REMARK 900 RELATED ID: 1W2K RELATED DB: PDB REMARK 900 TF7A_4380 COMPLEX REMARK 900 RELATED ID: 1W7X RELATED DB: PDB REMARK 900 FACTOR7 - 413 COMPLEX DBREF 1W8B H 16 257 UNP P08709 FA7_HUMAN 213 466 DBREF 1W8B L 88 144 UNP P08709 FA7_HUMAN 148 204 SEQRES 1 H 254 ILE VAL GLY GLY LYS VAL CYS PRO LYS GLY GLU CYS PRO SEQRES 2 H 254 TRP GLN VAL LEU LEU LEU VAL ASN GLY ALA GLN LEU CYS SEQRES 3 H 254 GLY GLY THR LEU ILE ASN THR ILE TRP VAL VAL SER ALA SEQRES 4 H 254 ALA HIS CYS PHE ASP LYS ILE LYS ASN TRP ARG ASN LEU SEQRES 5 H 254 ILE ALA VAL LEU GLY GLU HIS ASP LEU SER GLU HIS ASP SEQRES 6 H 254 GLY ASP GLU GLN SER ARG ARG VAL ALA GLN VAL ILE ILE SEQRES 7 H 254 PRO SER THR TYR VAL PRO GLY THR THR ASN HIS ASP ILE SEQRES 8 H 254 ALA LEU LEU ARG LEU HIS GLN PRO VAL VAL LEU THR ASP SEQRES 9 H 254 HIS VAL VAL PRO LEU CYS LEU PRO GLU ARG THR PHE SER SEQRES 10 H 254 GLU ARG THR LEU ALA PHE VAL ARG PHE SER LEU VAL SER SEQRES 11 H 254 GLY TRP GLY GLN LEU LEU ASP ARG GLY ALA THR ALA LEU SEQRES 12 H 254 GLU LEU MET VAL LEU ASN VAL PRO ARG LEU MET THR GLN SEQRES 13 H 254 ASP CYS LEU GLN GLN SER ARG LYS VAL GLY ASP SER PRO SEQRES 14 H 254 ASN ILE THR GLU TYR MET PHE CYS ALA GLY TYR SER ASP SEQRES 15 H 254 GLY SER LYS ASP SER CYS LYS GLY ASP SER GLY GLY PRO SEQRES 16 H 254 HIS ALA THR HIS TYR ARG GLY THR TRP TYR LEU THR GLY SEQRES 17 H 254 ILE VAL SER TRP GLY GLN GLY CYS ALA THR VAL GLY HIS SEQRES 18 H 254 PHE GLY VAL TYR THR ARG VAL SER GLN TYR ILE GLU TRP SEQRES 19 H 254 LEU GLN LYS LEU MET ARG SER GLU PRO ARG PRO GLY VAL SEQRES 20 H 254 LEU LEU ARG ALA PRO PHE PRO SEQRES 1 L 57 GLN LEU ILE CYS VAL ASN GLU ASN GLY GLY CYS GLU GLN SEQRES 2 L 57 TYR CYS SER ASP HIS THR GLY THR LYS ARG SER CYS ARG SEQRES 3 L 57 CYS HIS GLU GLY TYR SER LEU LEU ALA ASP GLY VAL SER SEQRES 4 L 57 CYS THR PRO THR VAL GLU TYR PRO CYS GLY LYS ILE PRO SEQRES 5 L 57 ILE LEU GLU LYS ARG HET CA H1258 1 HET 413 H1259 40 HETNAM CA CALCIUM ION HETNAM 413 (S)-[(R)-2-(4-BENZYLOXY-3-METHOXY-PHENYL)-2-(4- HETNAM 2 413 CARBAMIMIDOYL-PHENYLAMINO)-ACETYLAMINO]-PHENYL-ACETIC HETNAM 3 413 ACID FORMUL 3 CA CA 2+ FORMUL 4 413 C31 H30 N4 O5 FORMUL 5 HOH *59(H2 O) HELIX 1 1 ALA H 55 ASP H 60 5 6 HELIX 2 2 ASN H 60D ARG H 62 5 3 HELIX 3 3 GLU H 125 THR H 129C 1 8 HELIX 4 4 LEU H 129D VAL H 129G 5 4 HELIX 5 5 MET H 164 SER H 170B 1 9 HELIX 6 6 CYS H 191 SER H 195 5 5 HELIX 7 7 TYR H 234 ARG H 243 1 10 HELIX 8 8 ASN L 93 CYS L 98 5 6 HELIX 9 9 ILE L 138 GLU L 142 5 5 SHEET 1 HA 9 LYS H 20 VAL H 21 0 SHEET 2 HA 9 MET H 156 LEU H 163 -1 O VAL H 157 N LYS H 20 SHEET 3 HA 9 MET H 180 ALA H 183 -1 O CYS H 182 N LEU H 163 SHEET 4 HA 9 GLY H 226 ARG H 230 -1 O GLY H 226 N ALA H 183 SHEET 5 HA 9 THR H 206 GLY H 216 -1 O ILE H 212 N THR H 229 SHEET 6 HA 9 PRO H 198 TYR H 203 -1 O HIS H 199 N THR H 210 SHEET 7 HA 9 PHE H 135 GLY H 140 -1 O LEU H 137 N ALA H 200 SHEET 8 HA 9 MET H 156 LEU H 163 1 O MET H 156 N GLY H 140 SHEET 9 HA 9 LYS H 20 VAL H 21 -1 O LYS H 20 N VAL H 157 SHEET 1 HB 9 GLN H 30 VAL H 35 0 SHEET 2 HB 9 ALA H 39 LEU H 46 -1 O ALA H 39 N VAL H 35 SHEET 3 HB 9 TRP H 51 SER H 54 -1 O VAL H 53 N THR H 45 SHEET 4 HB 9 ALA H 104 LEU H 108 -1 O ALA H 104 N SER H 54 SHEET 5 HB 9 GLN H 81 PRO H 91 1 N ALA H 86 O ARG H 107 SHEET 6 HB 9 LEU H 64 LEU H 68 -1 O LEU H 64 N VAL H 85 SHEET 7 HB 9 GLN H 30 VAL H 35 -1 O LEU H 32 N VAL H 67 SHEET 8 HB 9 ALA H 39 LEU H 46 -1 O ALA H 39 N VAL H 35 SHEET 9 HB 9 GLN H 30 VAL H 35 -1 O VAL H 31 N GLY H 44 SHEET 1 LA 2 TYR L 101 SER L 103 0 SHEET 2 LA 2 SER L 111 ARG L 113 -1 O SER L 111 N SER L 103 SHEET 1 LB 2 TYR L 118 LEU L 120 0 SHEET 2 LB 2 CYS L 127 PRO L 129 -1 O THR L 128 N SER L 119 SSBOND 1 CYS H 22 CYS H 27 1555 1555 2.05 SSBOND 2 CYS H 42 CYS H 58 1555 1555 2.02 SSBOND 3 CYS H 122 CYS L 135 1555 1555 2.05 SSBOND 4 CYS H 168 CYS H 182 1555 1555 2.02 SSBOND 5 CYS H 191 CYS H 220 1555 1555 2.04 SSBOND 6 CYS L 91 CYS L 102 1555 1555 2.04 SSBOND 7 CYS L 98 CYS L 112 1555 1555 2.03 SSBOND 8 CYS L 114 CYS L 127 1555 1555 2.03 LINK OE1 GLU H 70 CA CA H1258 1555 1555 2.32 LINK O ASP H 72 CA CA H1258 1555 1555 2.55 LINK O GLU H 75 CA CA H1258 1555 1555 2.21 LINK OE2 GLU H 80 CA CA H1258 1555 1555 2.32 LINK CA CA H1258 O HOH H2013 1555 1555 2.44 CISPEP 1 PHE H 256 PRO H 257 0 1.77 SITE 1 AC1 5 GLU H 70 ASP H 72 GLU H 75 GLU H 80 SITE 2 AC1 5 HOH H2013 SITE 1 AC2 22 HIS H 57 ASP H 60 GLY H 97 THR H 99 SITE 2 AC2 22 ASP H 102 PRO H 170I ASP H 189 SER H 190 SITE 3 AC2 22 LYS H 192 SER H 195 VAL H 213 SER H 214 SITE 4 AC2 22 TRP H 215 GLY H 216 GLY H 219 GLY H 226 SITE 5 AC2 22 HOH H2048 CYS L 114 SER L 119 LEU L 120 SITE 6 AC2 22 LEU L 121 ALA L 122 CRYST1 82.846 82.846 147.768 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012071 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012071 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006767 0.00000